Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.580
-0.100 (-5.95%)
Jan 20, 2026, 4:00 PM EST - Market closed
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,426,778
Market Cap
197.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 9 | 0 | - |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | -5 | -35.71% |
| Dec 31, 2021 | 14 | 3 | 27.27% |
| Dec 31, 2020 | 11 | 3 | 37.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TLSA News
- 17 hours ago - Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab - GlobeNewsWire
- 4 days ago - Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares - GlobeNewsWire
- 4 days ago - Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million - GlobeNewsWire
- 11 days ago - Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - GlobeNewsWire
- 22 days ago - Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences to Ring the Closing Bell at Nasdaq - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer's Clinical Trial - GlobeNewsWire